ICD-10-PCS table XW1
Transfusion, Anatomical Regions
Table rows
4 · Body Part
- 3Peripheral Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- 2Plasma, Convalescent (Nonautologous)
7 · Qualifier
- 5New Technology Group 5
4 · Body Part
- 3Peripheral Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- 7Marnetegragene Autotemcel
7 · Qualifier
- ANew Technology Group 10
4 · Body Part
- 3Peripheral Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- BBetibeglogene Autotemcel
- COmidubicel
7 · Qualifier
- 8New Technology Group 8
4 · Body Part
- 3Peripheral Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- EHyperimmune Globulin
7 · Qualifier
- 7New Technology Group 7
4 · Body Part
- 3Peripheral Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- GAtidarsagene Autotemcel
7 · Qualifier
- 8New Technology Group 8
4 · Body Part
- 3Peripheral Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- HLovotibeglogene Autotemcel
7 · Qualifier
- 9New Technology Group 9
4 · Body Part
- 3Peripheral Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- JExagamglogene Autotemcel
7 · Qualifier
- 8New Technology Group 8
4 · Body Part
- 3Peripheral Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- SMozafancogene Autotemcel
- YNonautologous (Human) Fibrinogen Concentrate, Shelf-stable
7 · Qualifier
- BNew Technology Group 11
4 · Body Part
- 4Central Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- 2Plasma, Convalescent (Nonautologous)
7 · Qualifier
- 5New Technology Group 5
4 · Body Part
- 4Central Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- 7Marnetegragene Autotemcel
7 · Qualifier
- ANew Technology Group 10
4 · Body Part
- 4Central Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- BBetibeglogene Autotemcel
- COmidubicel
7 · Qualifier
- 8New Technology Group 8
4 · Body Part
- 4Central Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- EHyperimmune Globulin
7 · Qualifier
- 7New Technology Group 7
4 · Body Part
- 4Central Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- FEtuvetidigene Autotemcel
- GAtidarsagene Autotemcel
7 · Qualifier
- 8New Technology Group 8
4 · Body Part
- 4Central Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- HLovotibeglogene Autotemcel
7 · Qualifier
- 9New Technology Group 9
4 · Body Part
- 4Central Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- JExagamglogene Autotemcel
7 · Qualifier
- 8New Technology Group 8
4 · Body Part
- 4Central Vein
5 · Approach
- 3Percutaneous
6 · Device / Substance / Technology
- SMozafancogene Autotemcel
- YNonautologous (Human) Fibrinogen Concentrate, Shelf-stable
7 · Qualifier
- BNew Technology Group 11
All 21 valid codes in XW1
- XW13325Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5
- XW1337ATransfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10
- XW133B8Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133C8Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133E7Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
- XW133G8Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133H9Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9
- XW133J8Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
- XW133SBTransfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11
- XW133YBTransfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Peripheral Vein, Percutaneous Approach, New Technology Group 11
- XW14325Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach, New Technology Group 5
- XW1437ATransfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10
- XW143B8Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
- XW143C8Transfusion of Omidubicel into Central Vein, Percutaneous Approach, New Technology Group 8
- XW143E7Transfusion of Hyperimmune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7
- XW143F8Transfusion of Etuvetidigene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
- XW143G8Transfusion of Atidarsagene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
- XW143H9Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9
- XW143J8Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
- XW143SBTransfusion of Mozafancogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 11
- XW143YBTransfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Central Vein, Percutaneous Approach, New Technology Group 11